Literature DB >> 22144576

Augmented single-unit muscle sympathetic nerve activity in heart failure with chronic atrial fibrillation.

Tatsunori Ikeda1, Hisayoshi Murai, Shuichi Kaneko, Soichiro Usui, Daisuke Kobayashi, Manabu Nakano, Keiko Ikeda, Shin-Ichiro Takashima, Takeshi Kato, Masaki Okajima, Hiroshi Furusho, Masayuki Takamura.   

Abstract

Atrial fibrillation (AF) is a common complication in heart failure (HF) patients. However, it remains unclear whether irregular ventricular response patterns induced by AF increase sympathetic nerve activity. We measured resting multi- and single-unit muscle sympathetic nerve activity (MSNA) in 21 age-matched HF patients with chronic AF (n = 11) rhythm or sinus rhythm (SR, n = 10). The multi-unit MSNA, which was expressed as total activity, was similar between HF + AF patients and HF + SR patients. However, the single-unit MSNA in HF + AF patients was significantly greater than that in HF + SR patients (62 ± 9 spikes min(-1) vs. 42 ± 4 spikes min(-1), P < 0.05). Moreover, the incidence of multiple firing of single-unit MSNA within a given burst was augmented in HF + AF patients as compared with HF + SR patients (48 ± 8% vs. 26 ± 3%, P < 0.01). A significant negative relationship was observed between the reduced diastolic pressure induced by a prolonged cardiac interval in AF subjects and single-unit MSNA frequency within one cardiac interval in each HF + AF subject. The firing characteristics of single-unit MSNA were different between HF patients with AF and HF patients with SR; particularly, those with a prolonged long RR interval showed multiple firings of single-unit MSNA. These findings suggest that AF per se leads to the instantaneous augmentation of single-unit MSNA induced by decreased diastolic pressure, which might partially contribute to disease progression in HF patients.

Entities:  

Mesh:

Year:  2011        PMID: 22144576      PMCID: PMC3379697          DOI: 10.1113/jphysiol.2011.223842

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  26 in total

1.  A comparison of rate control and rhythm control in patients with atrial fibrillation.

Authors:  D G Wyse; A L Waldo; J P DiMarco; M J Domanski; Y Rosenberg; E B Schron; J C Kellen; H L Greene; M C Mickel; J E Dalquist; S D Corley
Journal:  N Engl J Med       Date:  2002-12-05       Impact factor: 91.245

2.  Effect of atrial fibrillation and an irregular ventricular response on sympathetic nerve activity in human subjects.

Authors:  Stephen L Wasmund; Jian-Ming Li; Richard L Page; Jose A Joglar; Robert C Kowal; Michael L Smith; Mohamed H Hamdan
Journal:  Circulation       Date:  2003-04-07       Impact factor: 29.690

3.  The discharge behaviour of single vasoconstrictor motoneurones in human muscle nerves.

Authors:  V G Macefield; B G Wallin; A B Vallbo
Journal:  J Physiol       Date:  1994-12-15       Impact factor: 5.182

4.  Chronic atrial fibrillation does not influence the magnitude of sympathetic overactivity in patients with heart failure.

Authors:  Paul A Gould; Murray D Esler; David M Kaye
Journal:  Eur Heart J       Date:  2003-09       Impact factor: 29.983

Review 5.  Behaviour of the adrenergic cardiovascular drive in atrial fibrillation and cardiac arrhythmias.

Authors:  Guido Grassi; Gino Seravalle; Giovanni Bertinieri; Giuseppe Mancia
Journal:  Acta Physiol Scand       Date:  2003-03

6.  Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure.

Authors:  J N Cohn; T B Levine; M T Olivari; V Garberg; D Lura; G S Francis; A B Simon; T Rector
Journal:  N Engl J Med       Date:  1984-09-27       Impact factor: 91.245

7.  Adverse consequences of high sympathetic nervous activity in the failing human heart.

Authors:  D M Kaye; J Lefkovits; G L Jennings; P Bergin; A Broughton; M D Esler
Journal:  J Am Coll Cardiol       Date:  1995-11-01       Impact factor: 24.094

8.  Beta blockers improve outcome in patients with heart failure and atrial fibrillation: U.S. carvedilol study.

Authors:  Karthik Ramaswamy
Journal:  Card Electrophysiol Rev       Date:  2003-09

9.  Mechanisms of sympathoexcitation: single-unit analysis of muscle vasoconstrictor neurons in awake OSAS subjects.

Authors:  Mikael Elam; David McKenzie; Vaughan Macefield
Journal:  J Appl Physiol (1985)       Date:  2002-07

10.  Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure.

Authors:  D M Kaye; G W Lambert; J Lefkovits; M Morris; G Jennings; M D Esler
Journal:  J Am Coll Cardiol       Date:  1994-03-01       Impact factor: 24.094

View more
  12 in total

1.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  Circulation       Date:  2014-03-28       Impact factor: 29.690

2.  Neurohormonal Blockade in Heart Failure.

Authors:  Thomas G von Lueder; Dipak Kotecha; Dan Atar; Ingrid Hopper
Journal:  Card Fail Rev       Date:  2017-04

Review 3.  Recording sympathetic nerve activity in conscious humans and other mammals: guidelines and the road to standardization.

Authors:  Emma C Hart; Geoffrey A Head; Jason R Carter; B Gunnar Wallin; Clive N May; Shereen M Hamza; John E Hall; Nisha Charkoudian; John W Osborn
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-03-31       Impact factor: 4.733

4.  Effect of pulmonary vein isolation on the relationship between left atrial reverse remodeling and sympathetic nerve activity in patients with atrial fibrillation.

Authors:  Yusuke Mukai; Hisayoshi Murai; Takuto Hamaoka; Hiroyuki Sugimoto; Oto Inoue; Chiaki Goten; Takashi Kusayama; Shin-Ichiro Takashima; Takeshi Kato; Soichiro Usui; Kenji Sakata; Shigeo Takata; Masayuki Takamura
Journal:  Clin Auton Res       Date:  2022-06-23       Impact factor: 5.625

Review 5.  Atrial fibrillation in heart failure.

Authors:  Rasmus Havmöller; Sumeet S Chugh
Journal:  Curr Heart Fail Rep       Date:  2012-12

6.  Skin sympathetic nerve activity and ventricular rate control during atrial fibrillation.

Authors:  Takashi Kusayama; Anthony Douglas; Juyi Wan; Anisiia Doytchinova; Johnson Wong; Gloria Mitscher; Susan Straka; Changyu Shen; Thomas H Everett; Peng-Sheng Chen
Journal:  Heart Rhythm       Date:  2019-11-19       Impact factor: 6.343

7.  Atrial fibrillation in patients with systolic heart failure: pathophysiology mechanisms and management.

Authors:  Ioanna Koniari; Eleni Artopoulou; Dimitrios Velissaris; Nicholas Kounis; Grigorios Tsigkas
Journal:  J Geriatr Cardiol       Date:  2021-05-28       Impact factor: 3.327

8.  Restoring Sinus Rhythm Improves Baroreflex Function in Patients With Persistent Atrial Fibrillation.

Authors:  Michael E Field; Stephen L Wasmund; Richard L Page; Mohamed H Hamdan
Journal:  J Am Heart Assoc       Date:  2016-02-23       Impact factor: 5.501

9.  Advantage of recording single-unit muscle sympathetic nerve activity in heart failure.

Authors:  Hisayoshi Murai; Masayuki Takamura; Shuichi Kaneko
Journal:  Front Physiol       Date:  2012-05-03       Impact factor: 4.566

Review 10.  Advancing Research on the Complex Interrelations Between Atrial Fibrillation and Heart Failure: A Report From a US National Heart, Lung, and Blood Institute Virtual Workshop.

Authors:  Sana M Al-Khatib; Emelia J Benjamin; Christine M Albert; Alvaro Alonso; Cynthia Chauhan; Peng-Sheng Chen; Anne B Curtis; Patrice Desvigne-Nickens; Jennifer E Ho; Carolyn S P Lam; Mark S Link; Kristen K Patton; Margaret M Redfield; Michiel Rienstra; Yves Rosenberg; Renate Schnabel; John A Spertus; Lynne Warner Stevenson; Mellanie True Hills; Adriaan A Voors; Lawton S Cooper; Alan S Go
Journal:  Circulation       Date:  2020-06-08       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.